Simultaneous RP-HPLC estimation of tizanidine, diclofenac potassium and paracetamol in tablets

G. Subramanian, P. Musmade, S. Agarwal, N. Udupa

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

A simple, fast, precise and accurate liquid chromatographic method was developed for the simultaneous estimation of tizanidine, diclofenac potassium and paracetamol in tablets. This combination is used for spasm and pain associated with musculoskeletal disorders. Drugs are chromatographed on a reverse phase Luna C18 column using a mobile phase, 25 mM phosphate buffer (pH 7.0) and acetonitrile in the ratio of 40:60 v/v. Carbamazepine was used as an internal standard. The retention time of Tizanidine, Diclofenac potassium, Paracetamol and carbamazepine was 5.00, 8.61, 3.43 and 11.68 min respectively. The validation of the proposed method was also carried out. The method was found to be linear (correlation co-efficient r>0.999), precise (residual standard deviation: 0.51% for paracetamol, 0.42% for diclofenac potassium and 0.81% for tizanidine), accurate (overall average recovery yields: 99.0% for tizanidine, 99.3% for diclofenac potassium and 98.6% for paracetamol) and selective. Due to its simplicity and accuracy the proposed method can be used for routine quality control analysis of these drugs in combination tablets.

Original languageEnglish
Pages (from-to)694-696
Number of pages3
JournalIndian Journal of Pharmaceutical Sciences
Volume66
Issue number5
Publication statusPublished - 2004

Fingerprint

Diclofenac
Acetaminophen
Tablets
High Pressure Liquid Chromatography
Carbamazepine
Spasm
Drug Combinations
Quality Control
Buffers
Phosphates
Pain
tizanidine
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

@article{39355db969e54babacf184f260ecf944,
title = "Simultaneous RP-HPLC estimation of tizanidine, diclofenac potassium and paracetamol in tablets",
abstract = "A simple, fast, precise and accurate liquid chromatographic method was developed for the simultaneous estimation of tizanidine, diclofenac potassium and paracetamol in tablets. This combination is used for spasm and pain associated with musculoskeletal disorders. Drugs are chromatographed on a reverse phase Luna C18 column using a mobile phase, 25 mM phosphate buffer (pH 7.0) and acetonitrile in the ratio of 40:60 v/v. Carbamazepine was used as an internal standard. The retention time of Tizanidine, Diclofenac potassium, Paracetamol and carbamazepine was 5.00, 8.61, 3.43 and 11.68 min respectively. The validation of the proposed method was also carried out. The method was found to be linear (correlation co-efficient r>0.999), precise (residual standard deviation: 0.51{\%} for paracetamol, 0.42{\%} for diclofenac potassium and 0.81{\%} for tizanidine), accurate (overall average recovery yields: 99.0{\%} for tizanidine, 99.3{\%} for diclofenac potassium and 98.6{\%} for paracetamol) and selective. Due to its simplicity and accuracy the proposed method can be used for routine quality control analysis of these drugs in combination tablets.",
author = "G. Subramanian and P. Musmade and S. Agarwal and N. Udupa",
year = "2004",
language = "English",
volume = "66",
pages = "694--696",
journal = "Indian Journal of Pharmaceutical Sciences",
issn = "0250-474X",
publisher = "Medknow Publications and Media Pvt. Ltd",
number = "5",

}

Simultaneous RP-HPLC estimation of tizanidine, diclofenac potassium and paracetamol in tablets. / Subramanian, G.; Musmade, P.; Agarwal, S.; Udupa, N.

In: Indian Journal of Pharmaceutical Sciences, Vol. 66, No. 5, 2004, p. 694-696.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Simultaneous RP-HPLC estimation of tizanidine, diclofenac potassium and paracetamol in tablets

AU - Subramanian, G.

AU - Musmade, P.

AU - Agarwal, S.

AU - Udupa, N.

PY - 2004

Y1 - 2004

N2 - A simple, fast, precise and accurate liquid chromatographic method was developed for the simultaneous estimation of tizanidine, diclofenac potassium and paracetamol in tablets. This combination is used for spasm and pain associated with musculoskeletal disorders. Drugs are chromatographed on a reverse phase Luna C18 column using a mobile phase, 25 mM phosphate buffer (pH 7.0) and acetonitrile in the ratio of 40:60 v/v. Carbamazepine was used as an internal standard. The retention time of Tizanidine, Diclofenac potassium, Paracetamol and carbamazepine was 5.00, 8.61, 3.43 and 11.68 min respectively. The validation of the proposed method was also carried out. The method was found to be linear (correlation co-efficient r>0.999), precise (residual standard deviation: 0.51% for paracetamol, 0.42% for diclofenac potassium and 0.81% for tizanidine), accurate (overall average recovery yields: 99.0% for tizanidine, 99.3% for diclofenac potassium and 98.6% for paracetamol) and selective. Due to its simplicity and accuracy the proposed method can be used for routine quality control analysis of these drugs in combination tablets.

AB - A simple, fast, precise and accurate liquid chromatographic method was developed for the simultaneous estimation of tizanidine, diclofenac potassium and paracetamol in tablets. This combination is used for spasm and pain associated with musculoskeletal disorders. Drugs are chromatographed on a reverse phase Luna C18 column using a mobile phase, 25 mM phosphate buffer (pH 7.0) and acetonitrile in the ratio of 40:60 v/v. Carbamazepine was used as an internal standard. The retention time of Tizanidine, Diclofenac potassium, Paracetamol and carbamazepine was 5.00, 8.61, 3.43 and 11.68 min respectively. The validation of the proposed method was also carried out. The method was found to be linear (correlation co-efficient r>0.999), precise (residual standard deviation: 0.51% for paracetamol, 0.42% for diclofenac potassium and 0.81% for tizanidine), accurate (overall average recovery yields: 99.0% for tizanidine, 99.3% for diclofenac potassium and 98.6% for paracetamol) and selective. Due to its simplicity and accuracy the proposed method can be used for routine quality control analysis of these drugs in combination tablets.

UR - http://www.scopus.com/inward/record.url?scp=33746869047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746869047&partnerID=8YFLogxK

M3 - Article

VL - 66

SP - 694

EP - 696

JO - Indian Journal of Pharmaceutical Sciences

JF - Indian Journal of Pharmaceutical Sciences

SN - 0250-474X

IS - 5

ER -